China Traditional Chinese Medicine Holdings Co. Limited - Laporan Laba Rugi (TTM)

China Traditional Chinese Medicine Holdings Co. Limited
HK ˙ SEHK ˙ HK0000056256
HK$ 2.16 ↑0.04 (1.89%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi China Traditional Chinese Medicine Holdings Co. Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 14,423 14,806 15,553 16,300 17,676 19,053 17,934 16,815 15,560 14,304 16,000 17,696 17,909 18,122 17,663 17,204 16,857 16,510 16,049 15,588
Change (%) 2.66 5.05 4.80 8.44 7.79 -5.87 -6.24 -7.47 -8.07 11.85 10.60 1.20 1.19 -2.53 -2.60 -2.02 -2.06 -2.79 -2.87
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 5,657 5,680 5,934 6,188 6,706 7,224 7,130 7,037 7,071 7,106 7,898 8,691 8,769 8,847 8,737 8,627 8,640 8,653 8,406 8,158
Change (%) 0.41 4.47 4.28 8.37 7.72 -1.29 -1.31 0.49 0.49 11.15 10.04 0.90 0.89 -1.25 -1.26 0.16 0.16 -2.86 -2.95
% of Revenue 39.22 38.36 38.15 37.96 37.94 37.91 39.76 41.85 45.45 49.68 49.37 49.11 48.97 48.82 49.46 50.14 51.25 52.41 52.38 52.34
Gross Operating Profit 8,766 9,126 9,619 10,112 10,971 11,829 10,804 9,778 8,488 7,198 8,102 9,005 9,140 9,274 8,926 8,578 8,217 7,856 7,643 7,430
Change (%) 4.11 5.40 5.12 8.49 7.83 -8.67 -9.49 -13.19 -15.20 12.55 11.15 1.50 1.48 -3.76 -3.90 -4.21 -4.39 -2.72 -2.79
% of Revenue 60.78 61.64 61.85 62.04 62.06 62.09 60.24 58.15 54.55 50.32 50.63 50.89 51.03 51.18 50.54 49.86 48.75 47.59 47.62 47.66
SG&A 6,074 6,334 6,662 6,990 7,781 8,572 7,917 7,262 6,411 5,559 6,331 7,102 7,280 7,457 7,318 7,180 6,881 6,583 6,495 6,408
Change (%) 4.28 5.18 4.92 11.31 10.16 -7.64 -8.27 -11.72 -13.28 13.88 12.19 2.49 2.43 -1.86 -1.89 -4.16 -4.34 -1.33 -1.35
% of Revenue 42.12 42.78 42.84 42.89 44.02 44.99 44.14 43.19 41.20 38.87 39.57 40.14 40.65 41.15 41.43 41.73 40.82 39.87 40.47 41.11
R&D 525 550 575 600 647 694 706 717 665 612 610 608 647 686 663 640 618 596 590 584
Change (%) 4.77 4.49 4.29 7.88 7.31 1.64 1.62 -7.35 -7.93 -0.32 -0.32 6.39 6.01 -3.33 -3.45 -3.43 -3.55 -0.99 -1.00
% of Revenue 3.64 3.72 3.70 3.68 3.66 3.64 3.94 4.27 4.27 4.28 3.81 3.44 3.61 3.78 3.75 3.72 3.67 3.61 3.68 3.75
OpEx 12,044 12,332 12,972 13,612 14,978 16,344 15,605 14,867 13,998 13,129 14,703 16,276 16,524 16,773 16,522 16,270 16,014 15,758 15,388 15,018
Change (%) 2.39 5.19 4.93 10.04 9.12 -4.52 -4.73 -5.85 -6.21 11.98 10.70 1.53 1.50 -1.50 -1.52 -1.57 -1.60 -2.35 -2.40
% of Revenue 83.51 83.29 83.40 83.51 84.73 85.78 87.02 88.42 89.97 91.79 91.89 91.98 92.27 92.56 93.54 94.57 95.00 95.45 95.88 96.35
Operating Income 2,379 2,474 2,581 2,688 2,699 2,709 2,328 1,948 1,561 1,175 1,297 1,420 1,384 1,349 1,142 934 843 752 661 569
Change (%) 4.00 4.34 4.16 0.38 0.38 -14.05 -16.35 -19.84 -24.75 10.42 9.43 -2.50 -2.57 -15.36 -18.14 -9.77 -10.83 -12.14 -13.82
% of Revenue 16.49 16.71 16.60 16.49 15.27 14.22 12.98 11.58 10.03 8.21 8.11 8.02 7.73 7.44 6.46 5.43 5.00 4.55 4.12 3.65
Interest Expense -274 -245 -243 -242 -232 -222 -216 -211 -216 -221 -224 -228 -213 -199 -188 -177 -174 -172 -155 -139
Change (%) -10.56 -0.61 -0.61 -4.07 -4.24 -2.56 -2.63 2.38 2.33 1.56 1.53 -6.27 -6.69 -5.56 -5.88 -1.52 -1.55 -9.60 -10.62
% of Revenue -1.90 -1.65 -1.56 -1.48 -1.31 -1.17 -1.21 -1.25 -1.39 -1.54 -1.40 -1.29 -1.19 -1.10 -1.06 -1.03 -1.03 -1.04 -0.97 -0.89
Net Income 1,562 1,663 1,762 1,861 1,897 1,933 1,675 1,417 1,091 764 847 930 1,107 1,285 1,101 917 486 54 -105 -265
Change (%) 6.47 5.95 5.61 1.93 1.89 -13.35 -15.41 -23.02 -29.90 10.80 9.75 19.12 16.05 -14.31 -16.70 -47.05 -88.87 -294.91 151.31
% of Revenue 10.83 11.23 11.33 11.42 10.73 10.14 9.34 8.42 7.01 5.34 5.29 5.25 6.18 7.09 6.24 5.33 2.88 0.33 -0.66 -1.70

Source: Capital IQ

Other Listings
US:CHIZF
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista